Ewen Sebastian, Nikolovska Alexandra, Zivanovic Ina, Kindermann Ingrid, Böhm Michael
Dtsch Med Wochenschr. 2016 Oct;141(21):1560-1564. doi: 10.1055/s-0042-102706. Epub 2016 Sep 28.
Chronic heart failure is one of the most common chronic diseases worldwide with increasing prevalence and incidence. Due to high morbidity and mortality a standardized and evidence-based therapy is crucial. This review presents new pharmacological and interventional developments, as well as new insights due to common comorbidities of patients with chronic heart failure like anemia and hyperkalemia.
慢性心力衰竭是全球最常见的慢性病之一,其患病率和发病率不断上升。由于高发病率和高死亡率,标准化和循证治疗至关重要。本综述介绍了新的药物和介入治疗进展,以及因慢性心力衰竭患者常见合并症(如贫血和高钾血症)而产生的新见解。